Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Nippon Shinyaku Co.,Ltd.. A complete text table follows the diagram.
Medicines provide 86% of revenue and nearly all operating profit, while rare-disease growth and royalties offset price cuts and generic competition.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Medicine | 1 | 68.6B | 86.1% of reported total |
| Functional Foods | 1 | 11.1B | 13.9% of reported total |
| External customer revenue | 2 | 79.6B | Reported six-month total · ¥79.6B |
| Operating profit | 3 | 19.6B | 24.6% operating margin |
| Operating costs & expenses | 3 | 60.1B | Arithmetic residual to reported operating profit |
| Profit before tax | 4 | 20.0B | Reported pretax result |
| Net non-operating income | 3 | 449M | Arithmetic bridge to reported pretax profit |
| Net profit attributable to owners | 5 | 15.8B | Reported parent-company result |
| Tax, attribution & other | 5 | 4.3B | Arithmetic bridge to owners' profit |
| From | To | Value |
|---|---|---|
| Medicine | External customer revenue | 68.6B |
| Functional Foods | External customer revenue | 11.1B |
| External customer revenue | Operating profit | 19.6B |
| External customer revenue | Operating costs & expenses | 60.1B |
| Operating profit | Profit before tax | 19.6B |
| Net non-operating income | Profit before tax | 449M |
| Profit before tax | Net profit attributable to owners | 15.8B |
| Profit before tax | Tax, attribution & other | 4.3B |